推荐产品
product name
Wnt拮抗剂I,IWR-1-endo, Wnt Antagonist I, IWR-1-endo, is a cell-permeable inhibitor of TNKS1/PARP5a (IC₅₀ = 131 nM) & TNKS2/PARP5b (IC₅₀= 56 nM). Suppress Wnt-stimulated transcription activity (IC₅₀ = 180 nM).
品質等級
化驗
≥95% (HPLC)
形狀
solid
製造商/商標名
Calbiochem®
儲存條件
OK to freeze
protect from light
顏色
off-white
溶解度
DMSO: 10 mg/mL
運輸包裝
ambient
儲存溫度
2-8°C
一般說明
一种细胞渗透性对亚氨基苯甲酰氨基喹啉,内非对映异构体,在体外自动PARsylation分析(IC50分别为131和56 nM)中显示抑制TNKS1/PARP5a和TNKS2/PARP5b的活性,并在基于L-Wnt-STF的报告分析(IC50=180 nM)中有效抑制Wnt刺激的转录活性,而对PARP1或PARP2几乎没有活性(IC50 >18.75 µM)。 尽管IWR-1-endo和XAV939都是可逆的Wnt途径抑制剂,并且在体外和体内表现出相似的药理作用,但IWR-1-endo通过与Axin的相互作用发挥其作用,而XAV939直接与TNK结合。
一种细胞渗透性对亚氨基苯甲酰氨基喹啉,内非对映异构体,在体外自动PARsylation分析(IC50分别为131和56 nM)中显示抑制TNKS1/PARP5a和TNKS2/PARP5b的活性,并在基于L-Wnt-STF的报告分析(IC50=180 nM)中有效抑制Wnt刺激的转录活性,而对PARP1或PARP2几乎没有活性(IC50 >18.75 µM)。 尽管IWR-1-endo和XAV939都是可逆的Wnt途径抑制剂,并且在体外和体内表现出相似的药理作用,但IWR-1-endo通过与Axin的相互作用发挥其作用,而XAV939直接与TNK结合。也可以25 mM的DMSO溶液(目录号504462)提供。
包裝
用惰性气体包装
警告
毒性:标准处理(A)
重構
复溶后,等分并冷冻保存(-20°C)。贮备溶液在-20°C下可稳定保存至多3个月。
其他說明
Chen, B., et al. 2009.Nature Chem. Biol.5, 100.
Huang, S.M., et al. 2009.Nature461, 614.
Huang, S.M., et al. 2009.Nature461, 614.
法律資訊
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
儲存類別代碼
11 - Combustible Solids
水污染物質分類(WGK)
WGK 3
閃點(°F)
Not applicable
閃點(°C)
Not applicable
其他客户在看
Aging, 12(8), 7411-7430 (2020-04-29)
Human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) have great potential in biomedical applications. However, the immature state of cardiomyocytes obtained using existing protocols limits the application of hPSC-CMs. Unlike adult cardiac myocytes, hPSC-CMs generate ATP through an immature metabolic pathway-aerobic glycolysis
Patient-Specific Retinal Organoids Recapitulate Disease Features of Late-Onset Retinitis Pigmentosa.
Frontiers in cell and developmental biology, 8, 128-128 (2020-03-27)
Although an increasing number of disease genes have been identified, the exact cellular mechanisms of retinitis pigmentosa (RP) remain largely unclear. Retinal organoids (ROs) derived from the induced pluripotent stem cells (iPSCs) of patients provide a potential but unvalidated platform
Pain, 161(3), 532-544 (2019-11-19)
Preventing and treating opioid dependence and withdrawal is a major clinical challenge, and the underlying mechanisms of opioid dependence and withdrawal remain elusive. We hypothesized that prolonged morphine exposure or chronic inflammation-induced μ-opioid receptor activity serves as a severe stress
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门